Two years since the start of the Covid-19 pandemic, the social and economic implications are still being felt on a global scale. The pandemic has impacted practically every phase of our lives and greatly influenced the cold chain logistics industry, bringing new challenges and requirements. This challenge is predicted only to get bigger as mRNA vaccine technology is applied to tackling other diseases – from cancer and flu to malaria and HIV. It’s a technology revolutionising the pharmaceutical sector and ushering in a new era of vaccinology. Muge Suner at Thermo King identifies a clear sign that ultra-cold temporary storage, as well as 15–25°C and 2–8°C temperature ranges, will be a common need for pharmaceutical transport and logistics in the future.